SGC Scientific Committee

The SGC Scientific Committee for 2011-2015 is currently being formed and will be posted here shortly.

The Phase 2007-2011 Scientific Committee comprised:

Dr. Kirk Clark (chair)

Executive Director, Protein Structure Group, Novartis Institutes for Biomedical Research
Nominating organisation: Novartis

Dr. Peter Dirks

Faculty, Hospital for Sick Children, Toronto
Nominating organisation: OMRI

Dr. Carl-Henrik Heldin

Branch Director, Ludwig Institute for Cancer Research
Nominating organisation: Swedish funders

Dr. Stephen Frye

Professor & Director of Center for Drug Discovery, University of North Carolina
Nominating organisation: CEO

Dr. Brett Finlay

Professor, University of British Columbia
Nominating organisation: Genome Canada

Dr. Lisa Shewchuk

Department Head, GSK
Nominating organisation: GSK

Dr. Stephen Soisson

Research Fellow, Global Structural Biology, Merck
Nominating organisation: Merck

Dr. Dave Stuart

MRC Professor of Structural Biology, University of Oxford
Nominating organisation: CEO

Prof. Anthony Pawson

Professor, Department of Molecular Genetics, University of Toronto
Nominating organisation: CIHR

Dr. Thomas Terwilliger

Structural Genomics Team Leader, Los Alamos National Laboratory, US
Nominating organisation: CEO

Prof. Mike Ferguson

Dean of Research for the College of Life Sciences, University of Dundee
Nominating organisation: Wellcome Trust